One Bio 

$0.000500
2
-$0.00-0% Thursday 20:00

Statistics

Day High
0.003
Day Low
0.003
52W High
0.003
52W Low
0.0002
Volume
5,764
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0.05
Dividend Yield
-
Dividend
-

Earnings

30NovExpected
Q4 2009
Q1 2010
Q3 2010
Q4 2010
Q1 2011
Q2 2011
Q3 2011
0
0.14
0.28
0.43
Expected EPS
N/A
Actual EPS
0.2153

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap233.78B
Amgen is a biotech firm that develops innovative therapeutics, directly competing in the biotechnology sector with One Bio.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences operates in the biopharmaceutical field, focusing on drugs for life-threatening diseases, overlapping with One Bio's market.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurological diseases and advanced biologics, competing in similar biotech niches as One Bio.
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Vertex Pharmaceuticals is known for creating treatments for serious diseases, directly competing with One Bio in the biotech innovation space.
Regeneron Pharmaceuticals
REGN
Mkt Cap81.77B
Regeneron Pharmaceuticals is involved in biopharmaceuticals, particularly in genetics-driven drug discovery, competing with One Bio's biotech solutions.
Alnylam Pharmaceuticals
ALNY
Mkt Cap31.73B
Alnylam Pharmaceuticals works on RNAi therapeutics, a cutting-edge area of biotech that could compete with One Bio's innovative approaches.
Incyte
INCY
Mkt Cap25.21B
Incyte operates in the development of proprietary therapeutics, sharing a competitive landscape with One Bio in the biopharmaceutical sector.
Exelixis
EXEL
Mkt Cap13.49B
Exelixis is a biotechnology company that develops small molecule therapies for cancer, competing in the oncology market with One Bio.
Neurocrine Biosciences
NBIX
Mkt Cap15.66B
Neurocrine Biosciences focuses on neurological and endocrine diseases, competing in specialized biotech areas relevant to One Bio's interests.

About

ONE Bio Corp. functions as an agritech enterprise that, alongside its subsidiaries, employs eco-friendly manufacturing methods to develop and produce foundational chemicals, botanical extracts, health supplements, and organic goods. The company's operations are divided into two primary segments: Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE division is dedicated to the creation, production, and market introduction of bio-ecological and non-prescription items. These products are formulated using compounds extracted from tobacco leaves and various other plant sources. Its offerings encompass chemical extracts such as Solanesol and Coenzyme Q10, in addition to herbal extracts like Resveratrol, 5-Hydroxytryptophan, and Ganoderma Tea, alongside granular and powdered fertilizers. Distribution for CHE products within China's bio-health and raw chemical intermediates sectors occurs through a network of independent third-party distributors, academic institutions, and hospital research facilities. Meanwhile, the OP unit manufactures a diverse array of health and energy beverages for both consumer and commercial use, organic food products, and fertilizers. These products, primarily bamboo-based, are marketed within the People's Republic of China. Its portfolio includes standard and vacuum-packed canned bamboo shoots, prepared mixed and seasoned vegetables, and the Japanese rice delicacy known as Kamameshi. This segment delivers its merchandise directly to supermarket chains, hotels, hospitals, and restaurants, augmented by sales through independent third-party distributors. Globally, ONE Bio Corp. exports its products to Japan, various Southeast Asian nations, European markets, and North America. Founded in 2000, the company was rebranded from ONE Holdings, Corp. to ONE Bio Corp. in November 2009 and is based in Aventura, Florida.
Show more...
CEO
Jian Ming Chan
Employees
358
Country
United States
ISIN
US6823232094

Listings

0 Comments

Share your thoughts

FAQ

What is One Bio stock price today?
The current price of ONBI is $0.00 USD — it has decreased by -0% in the past 24 hours. Watch One Bio stock price performance more closely on the chart.
What is One Bio stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange One Bio stocks are traded under the ticker ONBI.
Is One Bio stock price growing?
ONBI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year One Bio has showed a +150% increase.
What were One Bio earnings last quarter?
ONBI earnings for the last quarter are 0.22 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does One Bio have?
As of September 04, 2026, the company has 358 employees.
In which sector is One Bio located?
One Bio operates in the Materials sector.
When did One Bio complete a stock split?
The last stock split for One Bio was on September 15, 2010 with a ratio of 1:5.
Where is One Bio headquartered?
One Bio is headquartered in Aventura, United States.